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Purpose: Leber congenital amaurosis (LCA) is one of the most common causes of hereditary blindness in infants. To
date, mutations in 13 known genes and at two other loci have been implicated in LCA causation. An examination of the
known genes highlights several processes which, when defective, cause LCA, including photoreceptor development and
maintenance, phototransduction, vitamin A metabolism, and protein trafficking. In addition, it has been known for some
time that defects in sensory cilia can cause syndromes involving hereditary blindness. More recently evidence has come
to light that non-syndromic LCA can also be a “ciliopathy.”
Methods: Here we present a homozygosity mapping analysis in a consanguineous sibship that led to the identification of
a mutation in the recently discovered LCA5 gene. Homozygosity mapping was done using Affymetrix 10K Xba I Gene
Chip and a 24.5cM region on chromosome 6 (6q12- q16.3) was identified to be significantly homozygous. The LCA5
gene on this region was sequenced and cDNA sequencing also done to characterize the mutation.
Results: A c.955G>A missense mutation in the last base of exon 6 causing disruption of the splice donor site was identified
in both the affected sibs. Since there is a second consensus splice donor sequence 5 bp into the adjacent intron, this mutation
results in a transcript with a 5 bp insertion of intronic sequence, leading to a frameshift and premature truncation.
Conclusions: We report a missense mutation functionally altering the splice donor site and leading to a truncated protein.
This is the second report of LCA5 mutations causing LCA. It may also be significant that one affected child died at eleven
months of age due to asphyxia during sleep. To date the only phenotype unambiguously associated with mutations in this
gene is LCA. However the LCA5 gene is known to be expressed in nasopharynx, trachea and lungs and was originally
identified in the proteome of bronchial epithelium ciliary axonemes. The cause of death in this child may therefore imply
that LCA5 mutations can in fact cause a wider spectrum of phenotypes including respiratory disease.
Retinal  dystrophies  are  a  clinically  and  genetically
heterogeneous group of inherited diseases that cause severe
visual impairment. Estimated worldwide incidence is 1 in
3000 to 5000, and all three modes of Mendelian inheritance
are observed [1]. Leber congenital amaurosis (LCA) is an
autosomal recessive condition that appears at birth or in the
first few months of life. LCA is typically characterized by
nystagmus,  sluggish  or  no  pupillary  response,  and  severe
vision loss [1]. It is one of the most common genetic causes
of congenital visual impairment in infants and children. Genes
implicated in LCA causation include retinal guanylate cyclase
(GUCY2D)  on  chromosome  17p13.1  (LCA1),  RPE65  on
chromosome 1p31 (LCA2), RDH12 on chromosome 14q23.3
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(which may account for the LCA3 locus, though this remains
to  be  clarified),  AIPL1  on  chromosome  17p13.1  (LCA4),
RPGRIP1  on  chromosome  14q11  (LCA6),  CRX  on
chromosome 19q13.3 (LCA7), CRB1 on chromosome 1q31.3
(LCA8),  CEP290  on  chromosome  12q21.3  (LCA10),  and
IMPDH1 on chromosome 7q32.1 (LCA11) [2]. Mutations in
LRAT (4q32.1) and TULP1 (6p21.31) genes have also been
identified in recessive LCA. LCA9 has been mapped to 1p36,
but a causative gene has not been identified [2]. The location
of LCA5 was mapped to 6q11-q16 [3] and was later confirmed
in an independent pedigree [4]. Recent work has demonstrated
that the LCA5 causative gene is lebercilin, previously known
as C6orf152 [5].
In  this  study  we  describe  a  consanguineous  nuclear
pedigree in two sisters who have LCA. In this family we
performed  a  genome  wide  screen  for  homozygosity.  A
homozygous region was identified at the LCA5 locus, and a
novel mutation was identified in the LCA5 gene. This is the
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481second report of a mutation in the LCA5 gene and the fifth
mutation reported.
METHODS
Clinical examination: The research protocol was approved by
the ethics review board of the Vision Research Foundation,
Sankara Nethralaya. The study procedures were performed in
accordance with institutional guidelines and the Declaration
of Helsinki, and informed consent was obtained from each
participant. The two affected sisters, their unaffected parents
aged 30 (mother) and 36 years (father) and 50 ethnically
matched controls, which included 28 males and 22 females
with an average age of 62.32 (ranging between 38 and 79
years),  underwent  a  detailed  ophthalmic  examination
including recording of best corrected visual acuity, refraction,
slit lamp examination, and post dilatation binocular indirect
ophthalmoscopy. Additionally electroretinography was done
on patients.
DNA extraction: We drew 10 ml of heparinized blood from
both  affected  patients  and  their  parents  after  obtaining
informed consent from both parents. 10 ml of blood was also
drawn from 50 ethnically matched controls after obtaining
informed consent. Genomic DNA was extracted immediately
using  QIAamp  Blood  DNA  maxi  kit  (Qiagen,  GmbH,
Germany) according to the manufacturer’s instructions. Also
consent was obtained from the parents on behalf of the patients
because of their underage.
Genotyping:  Single  nucleotide  polymorphism  (SNP)
genotyping was performed with the GeneChip Mapping 10K
Xba I Array and Assay Kit (Affymetrix, Santa Clara, CA). All
incubations were done using a GeneAmp PCR system 9700
(Applied Biosystems, Foster City, CA). Internal positive and
negative GeneChip controls were performed in parallel using
the supplied genomic DNA. Xba I (New England Biolabs,
Ipswich, MA) was used to digest 250 ng genomic DNA for 2
h at 37 °C followed by heat inactivation for 20 min at 70 °C.
Digested  DNA  was  then  incubated  with  a  0.25  M  Xba  I
adaptor (Affymetrix) and DNA ligase (New England Biolabs)
in standard ligation buffer for 2 h at 16 °C followed by heat
inactivation  for  20  min  at  70  °C.  Ligated  products  were
amplified in quadruplicate using 10 μM generic primer in PCR
buffer II (Applied Biosystems) with 2.5 mM MgCl2/2.5 mM
deoxyribose  nucleotide  triphosphates  (dNTPs)/10  units  of
AmpliTaq Gold polymerase (Applied Biosystems) under the
following PCR conditions: 95 °C for 5 min, followed by 35
cycles (95 °C for 20 s, 59 °C for 15 s, and 72 °C for 15 s) and
a final extension at 72 °C for 7 min. Fragments ranging in size
from 250 to 1,000 bp were preferentially amplified under the
conditions  [6].  PCR  products  were  purified  with  Qiagen
MinElute 96 UF PCR Purification Kit and concentrated with
a Qiagen PCR purification column (Qiagen,) according to the
manufacturer's recommendations. A 10K genotyping assay
kit fragmentation reagent (Affymetrix) was used to digest 20
μg of DNA, which was then labeled with 30 U/μL terminal
deoxynucleotidyl transferase and 5 mM DNA labeling reagent
(Affymetrix 10K genotyping assay kit). After undergoing heat
inactivation at 95 °C for 10 min, samples were injected into
microarray cartridges and hybridized overnight. Microarrays
were washed in a fluidics station 450 (Affymetrix), followed
by  staining  with  streptavidin  Avidin  Phycoerythrin
(Molecular  Probes,  Eugene,  OR),  and  biotinylated
antistreptavidin (Vector Lab, Burlingame, CA), followed by
a final wash with SSPE buffer. Microarrays were scanned
according to manufacturer’s directions (Affymetrix). The data
was analysed using Exclude AR program (ExcludeAR sheet;
Excel, Microsoft, Redmond, WA) [7].
Sequencing of the LCA5 gene: The seven coding exons of the
LCA5 gene were amplified using 11 sets of primers with exon
7  amplified  using  five  sets  of  overlapping  primers  (same
primers used by den Hollander et al. [5]). A 20 ml reaction
was set up containing 10 mM Tris (pH 9.0), 50 mM KCl,
1.5mM MgCl2 and 0.01% gelatin, 1 mM dNTP each (GeNei,
Bangalore, India), 10 mM of each forward and reverse primer,
1U of Taq DNA polymerase (GeNei, Bangalore, India) and 5
mM  betaine  (Sigma  Aldrich,  St.  Louis,  MO).  100  ng  of
genomic DNA was amplified with initial denaturation at 94°C
for 5 min followed by 35 cycles of denaturation at 94 °C for
20 s, annealing at (56 °C for exons 1, 2a, 2b, 2c, 5, 6, 7e, 57
°C  for  exon  7a,  7b,  7c,  60  °C  for  7d,  and  at  65-58/58
touchdown for exon 3 and 4) for 20 s and extension at 72 °C
for 45 s and final extension at 72 °C for 7 min. PCR products
were digested with exonuclease I, E. coli, and shrimp alkaline
phosphatase (Fermentas Life Sciences, Glen Burnie, MD)
sequenced unidirectionally using BigDye Terminator v.3.1 kit
(Applied  Biosystems)  with  specific  primers  in  ABI3100
Avant, (Applied Biosystems). The sequences were analyzed
in Sequence Analysis software v 3.1.1. (Applied Biosystems,
Foster  City,  CA).  Any  DNA  sequence  variations  were
confirmed in the reverse direction. Fifty ethnically matched
normal controls were also amplified and sequenced to confirm
the mutation.
In silico splice site prediction: The effect of the single base
substitution identified in the last base position of exon 6 was
evaluated  using  a  splice  site  prediction  algorithm  (http://
violin.genet.sickkids.on.ca/~ali/splicesitefinder.html) [8,9].
RNA isolation and cDNA sequencing: RNA was isolated from
the  lymphocytes  separated  from  10-ml  heparinized  blood
samples of the affected (proband), unaffected parents, and one
unrelated normal control by using Trizol reagent (Sigma-
Aldrich,  St.  Louis,  MO),  according  to  the  manufacturer’s
instructions, and dissolved in diethyl pyrocarbonate (DEPC)–
treated water. Total RNA was used to generate a cDNA pool
by RT–PCR using a Qiagen Sensiscript reverse transcriptase
kit  (Qiagen,  GmbH,  Germany)  according  to  the
manufacturer’s instructions (Qiagen). PCR primers [10] for
the GAPDH housekeeping gene were used as the internal
control.  For  the  amplification  of  the  LCA5  gene,  exonic
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GCTGAAAGGAAAAGGGCATA  and  reverse
GGCTTGAAGTCTTCCATGGTT). PCR amplification was
performed using 50 ng of cDNA, 10 mM Tris (pH 9.0), 50 mM
KCl, 1.5 mM MgCl2 and 0.01% gelatin, 1 mM dNTP each
(GeNei, Bangalore, India), 10 μM each of forward and reverse
primer,  1U  of  Taq  DNA  polymerase  (GeNei)  and  5  mM
betaine (Sigma Aldrich) at 94 °C for 5 min followed by 35
cycles of 94 °C for 30 s, 57 °C for 45 s, 72 °C for 1 min, and
a final extension of 72 °C for 7 min.
RESULTS
A 7-month-old female of Indian ancestry presented with a
history  of  not  following  or  fixating  on  a  light  source.
Searching nystagmus and oculodigital reflex were present.
Bilateral  high  hyperopia  was  observed,  with  cycloplegic
refraction of +9.50 diopter sphere (DS)-5.00 diopter cylinder
(DC)×180° in the right eye and +7.00DS-3.00DC×180° in the
left  eye.  While  anterior  segment  evaluation  was  normal,
fundus  examination  revealed  diffuse,  bilateral  retinal
pigmentary abnormalities of pepper and salt type, arteriolar
attenuation,  and  a  metallic  sheen.  Optic  discs  appeared
normal.  A  diagnosis  of  LCA  was  confirmed  when  the
photopic  and  scotopic  electroretinogram  (ERG)  responses
were found to be nonrecordable, implicating the involvement
of both cone and rod photoreceptors. Reexamination of the
child when she was 6 years old revealed similar findings of
high hyperopia, nystagmus, retinal pigmentary alterations,
including white dots in the mid-periphery and an abnormal
sheen  in  the  macula  (Figure  1),  and  an  essentially
nonrecordable  ERG  (Figure  2A),  suggestive  of  LCA.
However,  no  history  of  mental  retardation,  cystic  renal
disease,  skeletal  disorders,  hydrocephalus  or  any  other
systemic associations were noted. No systemic complications
were seen on examination.
The proband’s younger sister (younger by 6 years) was
examined at the age of 5 months. She presented to the hospital
with poor vision and rotatory movements of the eyeball. On
examination the child was seen to follow light with poor
fixation.  Searching  nystagmus  was  present  along  with
bilateral  high  hyperopia.  Cycloplegic  refraction  was
+6.50DS-1.50DC×180°  in  the  right  eye  and
+8.25DS-1.50DC×170°  in  the  left  eye.  Anterior  segment
evaluation was normal, but as for the proband (old sister),
fundus examination revealed retinal pigmentary alterations of
pepper and salt type, mild arteriolar attenuation and a metallic
sheen. Six months after the examination the younger sister
died due to asphyxia during sleep.
Both parents had a normal visual function and normal
retina. Given that the parents were second cousins, and that
the two sisters presented with similar symptoms, which were
not reported in any other family members, we assigned an
autosomal recessive inheritance of LCA.
DNA from the two affected sisters and the unaffected
parents  was  hybridized  onto  GeneChips  that  were  then
scanned. Data analysis using Exclude AR program identified
two significant homozygously shared regions between the two
affected sisters (data not shown). The first was a 24.5 cM
region  on  chromosome  6  (6q12-q16.3)  made  up  of  139
consecutive SNPs, and the other was a 24.1 cM region on
chromosome  7  (7q21.1-q22.3)  that  was  composed  of  83
consecutive SNPs. Given the prior linkage to chromosome 6q
in LCA5 [3,4] we sequenced the LCA5 gene [5] in all four
pedigree members.
Sequence analysis of the LCA5 gene at 6q14.1 revealed
variations  in  exons  3  and  6.  In  exon  3  we  noted  a  T>C
polymorphism (c.71T>C, known SNP rs2655655), resulting
in a Lys24Ser substitution, with the affected siblings and
carrier parents all homozygous for the C allele. Also in exon
3, an A>C (c.77A>C, rs34068461) polymorphism, leading to
p.Asp26Ala, was seen in heterozygous form in the father and
as  a  homozygous  change  in  the  remaining  three  family
members.
In addition, a G>A variation was identified (c.955G>A)
in the last base of exon 6, which would be expected to cause
a  p.Ala319Thr  missense  mutation.  This  mutation  was
homozygous in the affected siblings (Figure 3A) while both
parents were heterozygous carriers (Figure 3B). This change
was  not  seen  in  50  normal  controls  of  a  similar  ethnic
background. As it affected the last base of exon 6, we used a
splice  site  prediction  algorithm  [8,9]  to  investigate  the
possibility this mutation might also lead to aberrant mRNA
splicing. The algorithm calculates scores for potential donor
and  acceptor  sequences  that  provide  an  estimate  of  the
strength of these sequences as sites for initiation of splicing.
Our analysis of the normal sequence adjacent to the 3' end of
exon 6 predicted two donor sites that turned out to be the wild-
type exon 6 donor-site and a second donor-site 5 bp into the
Figure  1.  Color  fundus  photograph  of  the  right  eye.  Fundus
photograph of the right eye of the proband showing midperipheral
white dots at the level of the retinal pigment epithelium, arteriolar
attenuation and an abnormal sheen in the macula.
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Figure 2. Full field electroretinogram in patient and parents. Full field
electroretinogram (ERG) of the proband (A), unaffected father (B),
and unaffected mother (C). The ERG is normal for the parents but
severely attenuated for the proband.
equally as potential donor sites (76.3 and 77.7% respectively).
However, when the mutated sequence was tested, the original
donor site was no longer predicted. This analysis suggested
that the mutation might cause exon 6 to be spliced at the
alternative  donor  site,  producing  an  mRNA  with  a  5  bp
insertion  of  the  intron,  breaking  the  reading  frame  and
potentially truncating the protein (Figure 4).
To test this hypothesis, we amplified cDNA spanning
exons 5, 6, and 7 of the LCA5 gene from the affected proband
and sequenced. The results obtained were as predicted. The
proband  was  found  to  have  a  5  bp  insertion  of  intronic
sequence (Figure 3C), causing a frameshift in the mRNA,
while the control showed the normal sequence (Figure 3D).
The  c.955G>A  substitution  mutation  is  therefore  not  a
missense mutation but a nonsense mutation, which will lead
either to insertion of 29 new amino acids sequence before
premature truncation.
DISCUSSION
Recently  den  Hollander  et  al.  [5]  demonstrated  that  the
defective gene at the LCA5 locus encodes the ciliary protein
lebercilin [3]. They identified one nonsense mutation, two
Figure  3.  Mutation  analysis  of  LCA5  gene.  A:  Sequence
chromatogram of the LCA5 gene showing c.955G>A homozygous
mutation  in  the  genomic  DNA  of  the  affected  patient.  The
homozygous  mutation  is  indicated  by  the  arrow.  B:  Sequence
chromatogram of the LCA5 gene showing c.955G>A heterozygous
change  in  the  genomic  DNA  of  the  unaffected  father.  The
heterozygous variation is indicated by the arrow. C: cDNA sequence
of the LCA5 gene of the affected proband with the mutated splice
site. The black square box and the arrow indicate the mutated base.
The green dashed box indicates the 5 base insertion of the adjacent
intron due to the donor splice site mutation. D: cDNA sequence of a
normal control showing the wild type base as indicated by the arrow
and the underlined sequence annotation.
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484frameshift  mutations,  and  one  promoter  mutation  in
consanguineous  LCA  families  [5].  Here  we  used
homozygosity mapping in a consanguineous Indian pedigree
to identify a novel LCA5 mutation, c.955G>A, that disrupts
the correct exon 6 splice donor site and leads to splicing at a
cryptic  donor  consensus  sequence  5  bp  into  the  adjacent
intron.  This  finding  further  underlines  the  importance  of
homozygosity mapping as a tool for identifying genes and
mutations involved in recessively inherited diseases, and of
nonsense mutations in the LCA5 gene as a cause of LCA. The
mutation  identified  is  interesting  as  it  serves  to  further
emphasize that defects in splicing, as well as direct alterations
of the protein code, can cause human inherited diseases. A
similar change in the third base of a codon could easily be
overlooked in such analyses since at first glance it is a silent
change in terms of its effect on the mRNA code.
The  phenotype  of  the  family  described  herein  is
consistent  with  a  diagnosis  of  LCA  and  is  similar  to  the
phenotype described previously in LCA5 patients of the same
age [4]. Despite the fact that LCA is a congenital abnormality,
the previous report suggested some progression of phenotype
with  age,  with  macular  staphyloma  as  a  complication  of
disease in adulthood. The two patients observed in this report
were both below ten years of age on examination and had no
staphylomatous  changes.  The  relatively  consistent  LCA5
phenotype, the recessive mode of inheritance, and the growing
list of null mutations all point to the LCA5 phenotype being
the result of a lack of functional lebercilin protein rather than
the presence of a defective protein. It is not yet known whether
truncated proteins are produced in patients or whether the
mutated mRNAs are degraded by nonsense mediated decay
[11]. However the mutated cDNA was readily amplified from
lymphocyte RNA, suggesting that the mutated mRNA is still
present at a significant level.
It may be significant that the second affected sibling died
of respiratory failure. LCA5 is known to be a ciliopathy, a
disease resulting from a defect in formation or function of
cilia. Cilia proteins are essential in the retina because the outer
Figure 4. Schematic representation of the 3' end of the exon 6 of the
LCA5 gene. The figure represents 3' portion of the normal and mutant
sequence of the exon 6 of the LCA5 gene. Nucleotides in uppercase
represent exonic sequence and that in small lower case represent
intronic sequences. The nucleotide in uppercase and in bold represent
the last base of the exon and the site of mutation. The first vertical
bar in the normal sequence represent the real splice donor site and
the second vertical bar represent additional/alternative splice donor
site, which is activated in the event of absence of the real splice donor
site.
segments of rod and cone photoreceptors are highly adapted
cilia. However, most human cells are ciliated and therefore
the majority of these proteins would be expected to serve
similar functions elsewhere in the body. To date all reported
cases of LCA associated with mutations in or linkage to the
LCA5 gene lack other syndromic features. This is surprising
as other ciliopathies affect the kidney and other organs, and
the LCA5 gene is known to be expressed in nasopharynx,
trachea,  and  lungs  and  was  originally  identified  in  the
proteome of bronchial epithelium ciliary axonemes [5]. If
other LCA5 cases were found to have respiratory defects this
might imply a defect of motor as well as sensory cilia in these
patients.
In summary, this is the second report of LCA5 mutations
in  LCA  patients,  further  emphasizing  the  significance  of
mutations  in  this  gene  as  a  cause  of  LCA.  The  mutation
identified is novel and causes disease by disrupting an existing
splice donor site so that a cryptic donor site in the adjacent
intron  is  favored,  leading  to  a  frameshift  in  the  resultant
mRNA.
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